ReviewObesity reviews : an official journal of the International Association for the Study of Obesity2026
Phytocompounds That Target White Adipose Tissue for Weight Loss: A Review Spanning From Ucp1 Induction in Rodents to Human Clinical Trials.
Review in Obesity reviews : an official journal of the International Association for the Study of Obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Most drugs and supplements for weight loss decrease appetite and food intake, resulting in loss of lean mass and fat mass. An ideal strategy for weight loss would be to directly target adipocytes and stimulate mitochondrial thermogenesis fueled by fatty acid oxidation. Many phytocompounds and food components can act directly on rodent adipocytes to stimulate expression of Ucp1, a mitochondrial protein and marker for thermogenic capacity. Expression of Ucp1 is highly inducible in rodent adipocytes and correlates with lower adiposity after high-fat diet consumption. The aim of this review is to determine whether the natural compounds that stimulate expression of rodent Ucp1 have the same effect in human adipocytes and translate to reduction of body weight in human clinical trials. Sixteen natural compounds that induce Ucp1 expression in rodent primary adipocytes or adipose tissue were identified from literature searches of PubMed and Web of Science databases. Of these, resveratrol, naringenin, curcumin, menthol, genistein, and artepillin C induce UCP1 in human adipocytes. The most active phytocompounds in human adipocytes bypass receptor signaling and bind nuclear receptors that act on promoter elements to induce thermogenesis genes. Resveratrol, naringenin, curcumin, epigallocatechin-3-gallate, fucoxanthin, menthol, provitamin A carotenoids, and capsaicin have been evaluated in clinical trials for weight loss. Naringenin and curcumin stimulate weight loss in multiple clinical trials. Extracts enriched in the active component stimulate greater clinical weight loss than any single active component. We conclude that specific natural compounds that target adipose tissue can stimulate human energy expenditure and meaningful weight loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.